“Novoseven - Drug Insights, 2015” – A DelveInsight’s Report

NEW DELHI - Aug. 17, 2015 - PRLog -- The Novoseven - Drug Insights, 2015 report provides client with details on the ongoing enterprises and the upcoming business opportunities related to new interventions. It comprehensively includes:

· Marketed details and the Global API manufacturers details across the globe along with the location

· Other clinical development of this drug

· Total sales estimation along with sales forecast till 2017

· Detailed clinical assessment, patent information

· SWOT analysis for Novoseven drug insights

The report on Novoseven - Drug Insights, 2015 will help in evaluating market scenario and harness opportunities for development by identifying the key patent expiry details and exclusivity with respect to Novoseven drug. In addition to this the detail sales forecast and SWOT analysis will help companies in finding collaborations and licensing partners.

DelveInsight is offering the Report at a price of USD 1000 as a single user license, USD 2000 as a site license and USD 3000 as a Global/Enterprise License.

For more information on Pipeline Insight Reports, email at info@delveInsight.com

About Us

DelveInsight is a leading Business Consulting and Market Research Firm. They help clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.